Oritsegbubemi Adekola, MD

Oritsegbubemi Adekola, MD

Assistant Professor
Internal Medicine

    About me

    Gender

    Female

    Education & training

    Positions
    Nephrology Specialist

    Clinical trials

    Trial
    Internal Medicine

    REFRESH: A Phase 3, Double-blind, Placebo-controlled and Open-label Efficacy and Long-term Safety Study of Firibastat (QGC001) Administered Orally, Once Daily, for Up to 48 Weeks in Patients with Difficult-to-treat/Resistant Hypertension

    Active recruiting

    PURPOSE: The purpose of this clinical trial is to assess the effects of firibastat on blood pressure, in patients with difficult-to-treat and/or treatment-resistant hypertension

    Contact: Emily Starkey 217-545-7616
    Trial
    Internal Medicine

    RADIANCE Continued Access Protocol (CAP): A study of the ReCor Medical Paradise System in Clinical Hypertension

    Active recruiting

    PURPOSE: This purpose of this clinical trial is to find out if a medical device called the Paradise Renal Denervation System
    can lower blood pressure in patients who have hypertension

    Contact: Emily Starkey 217-545-7616